logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table HSR-3. Estimated number of clients in methadone treatment and of clients receiving any opioid substitution [see all tables in this series...]

Part (i): Estimates of clients in methadone treatment or opioid substitution in EU-27, Croatia, Turkey and Norway, 2005 and 2006

CountryMethadone substitution clients 2005All substitution clients 2005Methadone substitution clients 2006All substitution clients 2006
Belgium(1)1155012300n.a.n.a.
Bulgaria92092011001100
Czech Republic(2)52525925743700
Denmark(3)55256289n.a.n.a.
Germany(4)49410610004134564500
Estonia500500602602
Ireland(5)8962902894289428
Greece2420359625203950
Spain(6)833748346933867n.a.
France(7)16850994461487597468
Italy(8)7640096972n.a.97434
Cyprus(9)0000
Latvia(10)5016955164
Lithuania410414381381
Luxembourg(11)1084108410441044
Hungary766766853853
Malta(12)671671n.a.n.a.
Netherlands(13)125641345012500n.a.
Austria(14)n.a.7343n.a.8120
Poland96996912211221
Portugal(15)11315210541226522922
Romania570570n.a.n.a.
Slovenian.a.n.a.n.a.n.a.
Slovakia(16)505525n.a.n.a.
Finland(17)2668005301000
Sweden1027229412702739
United Kingdom (England)(18)109500135000119000146500
United Kingdom (Scotland)1922719227n.a.n.a.
United Kingdom (Northern Ireland)(19)157346n.a.463
Croatia886n.a.11861949
Turkey0000
Norway2791398727904576

Notes:

 Where data are not available for a country, the table entry is left empty. 

 If not mentioned otherwise, data refer to individuals receiving treatment in the reporting year. 

 For information on client population covered, estimation processes and other notes by country see part ii. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Standard Tables 24 on 'Treatment availability' submitted by NFPs in 2006 and Reitox national reports 2007

 Best, D. and Campbell, A. (2006) Summary of the NTA's national prescribing audit. NTA Research Briefing 19, June 2006.  

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008